Lionbridge (Nasdaq: LIOX) today announced that it has signed a new, three-year master services agreement with a multi-billion dollar biotech ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE